Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia

ClinicalTrials.gov ID: NCT01114217

Public ClinicalTrials.gov record NCT01114217. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 11:47 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Open-Label Extension Trial of the Safety and Efficacy of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To evaluate the safety and efficacy of ferumoxytol for the episodic treatment of iron deficiency anemia (IDA).

Study identification

NCT ID
NCT01114217
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AMAG Pharmaceuticals, Inc.
Industry
Enrollment
634 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 27, 2010 (Actual)
Primary completion
Sep 24, 2012 (Actual)
Completion
Apr 23, 2013 (Actual)
Last update posted
Apr 21, 2022

2010 – 2013

United States locations

U.S. sites
103
U.S. states
26
U.S. cities
79
Facility City State ZIP Site status
Clinical Trial Site Birmingham Alabama — —
Clinical Trial Site Mobile Alabama — —
Clinical Trial Site Montgomery Alabama 36106 —
Clinical Trial Site Montgomery Alabama 36116 —
Clinical Trial Site Phoenix Arizona 85015 —
Clinical Trial Site Phoenix Arizona 85032 —
Clinical Trial Site Tucson Arizona 85710 —
Clinical Trial Site Tucson Arizona 85712 —
Clinical Trial Site Anaheim California — —
Clinical Trial Site Bakersfield California — —
Clinical Trial Site Buena Park California — —
Clinical Trial Site Colton California — —
Clinical Trial Site Los Angeles California 90036 —
Clinical Trial Site Los Angeles California 90057 —
Clinical Trial Site Los Angeles California — —
Clinical Trial Site Mission Hills California — —
Clinical Trial Site Orange California — —
Clinical Trial Site San Diego California 92103 —
Clinical Trial Site San Diego California 92121 —
Clinical Trial Site San Diego California 92123 —
Clinical Trial Site Pueblo Colorado — —
Clinical Trial Site Bristol Connecticut — —
Clinical Trial Site Groton Connecticut — —
Clinical Trial Site Boynton Beach Florida 33426 —
Clinical Trial Site Boynton Beach Florida 33472 —
Clinical Trial Site Clearwater Florida 33756 —
Clinical Trial Site Clearwater Florida 33759 —
Clinical Trial Site Hialeah Florida — —
Clinical Trial Site Holiday Florida — —
Clinical Trial Site Inverness Florida — —
Clinical Trial Site Margate Florida — —
Clinical Trial Site Miami Florida 33126 —
Clinical Trial Site Miami Florida 33135 —
Clinical Trial Site Miami Florida 33143 —
Clinical Trial Site Miami Florida 33144 —
Clinical Trial Site Miami Florida 33175 —
Clinical Trial Site Miami Lakes Florida — —
Clinical Trial Site Naples Florida — —
Clinical Trial Site Vero Beach Florida — —
Clinical Trial Site West Palm Beach Florida — —
Clinical Trial Site Zephyrhills Florida — —
Clinical Trial Site Atlanta Georgia 30308 —
Clinical Trial Site Atlanta Georgia 30312 —
Clinical Trial Site Atlanta Georgia 30342 —
Clinical Trial Site Decatur Georgia — —
Clinical Trial Site Dublin Georgia — —
Clinical Trial Site Sandy Springs Georgia — —
Clinical Trial Site Stockbridge Georgia — —
Clinical Trial Site Aurora Illinois — —
Clinical Trial Site Chicago Illinois 60616 —
Clinical Trial Site Skokie Illinois 60076 —
Clinical Trial Site Skokie Illinois — —
Clinical Trial Site Springfield Illinois — —
Clinical Trial Site Wichita Kansas — —
Clinical Trial Site New Orleans Louisiana — —
Clinical Trial Site Bethesda Maryland — —
Clinical Trial Site Hollywood Maryland — —
Clinical Trial Site Bay City Michigan 48706 —
Clinical Trial Site Bay City Michigan — —
Clinical Trial Site Wyoming Michigan — —
Clinical Trial Site Kansas City Missouri — —
Clinical Trial Site Las Vegas Nevada — —
Clinical Trial Site Lawrenceville New Jersey — —
Clinical Trial Site Neptune City New Jersey — —
Clinical Trial Site Plainsboro New Jersey — —
Clinical Trial Site Voorhees Township New Jersey — —
Clinical Trial Site Albuquerque New Mexico — —
Clinical Trial Site Brooklyn New York — —
Clinical Trial Site New York New York 10038 —
Clinical Trial Site Raleigh North Carolina — —
Clinical Trial Site Winston-Salem North Carolina — —
Clinical Trial Site Canton Ohio — —
Clinical Trial Site Carlisle Ohio — —
Clinical Trial Site Cincinnati Ohio 45224 —
Clinical Trial Site Cincinnati Ohio 45242 —
Clinical Trial Site Columbus Ohio 43231 —
Clinical Trial Site Marion Ohio 43302 —
Clinical Trial Site Marion Ohio — —
Clinical Trial Site Mentor Ohio — —
Clinical Trial Site Middletown Ohio — —
Clinical Trial Site Zanesville Ohio — —
Clinical Trial Site Norman Oklahoma — —
Clinical Trial Site Jenkintown Pennsylvania — —
Clinical Trial Site Levittown Pennsylvania — —
Clinical Trial Site Columbia South Carolina — —
Clinical Trial Site Greer South Carolina — —
Clinical Trial Site Myrtle Beach South Carolina — —
Clinical Trial Site North Charleston South Carolina — —
Clinical Trial Site Rapid City South Dakota — —
Clinical Trial Site Arlington Texas — —
Clinical Trial Site Dallas Texas — —
Clinical Trial Site Houston Texas 77030 —
Clinical Trial Site Houston Texas 77074 —
Clinical Trial Site Houston Texas — —
Clinical Trial Site Laredo Texas — —
Clinical Trial Site Longview Texas — —
Clinical Trial Site San Antonio Texas 78205 —
Clinical Trial Site San Antonio Texas 78215 —
Clinical Trial Site San Antonio Texas 78229 —
Clinical Trial Site San Antonio Texas — —
Clinical Trial Site Orem Utah — —
Clinical Trial Site Chesapeake Virginia — —
Clinical Trial Site Norfolk Virginia — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 37 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01114217, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 21, 2022 · Synced Nov 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01114217 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →